Cargando…
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
Progressive multiple sclerosis (PMS) is clinically distinct from relapsing–remitting MS (RRMS). In PMS, clinical disability progression occurs independently of relapse activity. Furthermore, there is increasing evidence that the pathological mechanisms of PMS and RRMS are different. Current therapeu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294105/ https://www.ncbi.nlm.nih.gov/pubmed/35289375 http://dx.doi.org/10.1007/s13311-022-01214-x |